• OPEN AN ACCOUNT
Indian Indices
Nifty
25,044.35 72.45
(0.29%)
Sensex
82,055.11 158.32
( 0.19%)
Bank Nifty
56,461.90 402.55
( 0.72%)
Nifty IT
38,417.95 3.85
( 0.01%)
Global Indices
Nasdaq
42,601.30 373.47
(0.88%)
Dow Jones
6,045.90 57.06
(0.95%)
Hang Seng
38,777.68 423.59
(1.10%)
Nikkei 225
8,758.99 0.95
(0.01%)
Forex
USD-INR
86.50 -0.18
(-0.20%)
EUR-INR
99.61 0.16
(0.17%)
GBP-INR
116.27 -0.12
(-0.11%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Indian Metals & Ferro Alloys Ltd
Industry :  Mining / Minerals / Metals
BSE Code
ISIN Demat
Book Value()
533047
INE919H01018
430.4147132
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IMFA
10.27
3882.27
EPS(TTM)
Face Value()
Div & Yield %
70.08
10
2.78
 

As on: Jun 24, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
121.73 0.51 8076 0.00
Stock Price Details
Open Price() 122.50
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 125.00
Today's Low () 117.25
52-Week High () 133.5
152-Week Low () 30
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 0
Book Value -6.931875
Market Cap (.Cr) 448.31
Face Value 10
Market Lot 100
AGM Date Sep
Book Closure Date Dec
ISIN No. INE102E01018


News
Oxygenta Pharmaceutical Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Oxygenta Pharmaceutical Ltd - Announcement under Regulation 30 (LODR)-Change in Management Control
Oxygenta Pharmaceutical Ltd - Announcement under Regulation 30 (LODR)-Resignation of Director
Oxygenta Pharmaceutical Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate
Oxygenta Pharmaceutical Ltd - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Oxygenta Pharmaceutical Ltd - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
Oxygenta Pharmaceutical reports standalone net loss of Rs 2.15 crore in the March 2025 quarter
Oxygenta Pharmaceutical to discuss results
Oxygenta Pharmaceutical Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Oxygenta Pharmaceutical Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
More
Corporate Details
Incoporation Year   : 1990
Chairman : Sai Sudhakar Vankineni
Bussiness Group :
Registered Office
Oxygenta Pharmaceutical Ltd
Survey No 252/1 Aroor Village,
Sadasivapet Mandal,
Medak,
Telangana-502291
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-08455-250080/250280
Fax:91-08455-250090
Fax:91-22-66317458
E-Mail : cs@ssorganics.co.in; md@ssorganics.co.in; info@sso
URL : http://www.oxygentapharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi